• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子-β:CD4+CD25+调节性T细胞介导的免疫抑制中缺失的环节。

TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression.

作者信息

Chen WanJun, Wahl Sharon M

机构信息

Cellular Immunology Section, Oral Infection and Immunity Branch, NIDCR, NIH, Room 332, Building 30, Bethesda, MD 20892-4352, USA.

出版信息

Cytokine Growth Factor Rev. 2003 Apr;14(2):85-9. doi: 10.1016/s1359-6101(03)00003-0.

DOI:10.1016/s1359-6101(03)00003-0
PMID:12651220
Abstract

A unique population of CD4(+) T lymphocytes that constitutively express CD25 has been recognized as anergic/suppressor cells. While the immunosuppressive activity of these CD4(+)CD25(+) cells has been validated and implicated in tolerance, autoimmunity, transplantation, cancer and infectious diseases, the mechanism(s) by which they function still remains controversial. Although the involvement of TGF-beta was initially discounted, emerging evidence now links this cytokine with CD4(+)CD25(+) T cell-mediated suppression of antigen-activated T cells. In this perspective, we summarize recently published studies, as well as our own data, which shed light on how cell membrane-bound TGF-beta can deliver a regulatory signal to target cells via a contact-dependent process. Moreover, suppressor T cell function is a complex process, tightly regulated by multiple factors, including IL-2, cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) and glucocorticoid induced TNF receptor (GITR). Collectively, multiple previously unconnected puzzle pieces are beginning to be linked into a more coherent, albeit incomplete picture of CD4(+)CD25(+) T cell-mediated suppression.

摘要

一群组成性表达CD25的独特CD4(+) T淋巴细胞已被认定为无反应性/抑制性细胞。虽然这些CD4(+)CD25(+)细胞的免疫抑制活性已得到验证,并与耐受性、自身免疫、移植、癌症和传染病有关,但其发挥作用的机制仍存在争议。尽管最初认为转化生长因子-β(TGF-β)不参与其中,但新出现的证据现在将这种细胞因子与CD4(+)CD25(+) T细胞介导的对抗原激活T细胞的抑制联系起来。从这个角度来看,我们总结了最近发表的研究以及我们自己的数据,这些研究揭示了细胞膜结合的TGF-β如何通过接触依赖过程向靶细胞传递调节信号。此外,抑制性T细胞功能是一个复杂的过程,受到多种因素的严格调控,包括白细胞介素-2(IL-2)、细胞毒性T淋巴细胞相关抗原-4(CTLA-4)和糖皮质激素诱导的肿瘤坏死因子受体(GITR)。总的来说,多个以前未关联的拼图碎片开始被拼凑成一幅更连贯、尽管仍不完整的CD4(+)CD25(+) T细胞介导的抑制图景。

相似文献

1
TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression.转化生长因子-β:CD4+CD25+调节性T细胞介导的免疫抑制中缺失的环节。
Cytokine Growth Factor Rev. 2003 Apr;14(2):85-9. doi: 10.1016/s1359-6101(03)00003-0.
2
Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta.CD4(+)CD25(+)调节性T细胞的细胞接触依赖性免疫抑制由细胞表面结合的转化生长因子β介导。
J Exp Med. 2001 Sep 3;194(5):629-44. doi: 10.1084/jem.194.5.629.
3
A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.转化生长因子β在人外周血CD4+CD25+调节性T细胞的产生和扩增中的作用。
J Immunol. 2001 Jun 15;166(12):7282-9. doi: 10.4049/jimmunol.166.12.7282.
4
Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.人CD25 + CD4 + T抑制细胞克隆产生转化生长因子β,但不产生白细胞介素10,且不同于1型调节性T细胞。
J Exp Med. 2002 Nov 18;196(10):1335-46. doi: 10.1084/jem.20021139.
5
TGF-beta-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling.CTLA-4信号传导促进了CD4+CD25+ T细胞介导的TGF-β抑制作用。
J Immunol. 2006 Aug 15;177(4):2331-9. doi: 10.4049/jimmunol.177.4.2331.
6
Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.在转化生长因子-β共刺激的CD4+CD25-T细胞中获得无反应性和抑制活性。
Int Immunol. 2004 Aug;16(8):1203-13. doi: 10.1093/intimm/dxh123. Epub 2004 Jul 5.
7
Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells.滤泡性淋巴瘤瘤内CD4+CD25+GITR+调节性T细胞可有效抑制经CD3/CD28共刺激的自体和同种异体CD8+CD25-及CD4+CD25-T细胞。
J Immunol. 2007 Apr 1;178(7):4051-61. doi: 10.4049/jimmunol.178.7.4051.
8
CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.CD4(+)CD25(+)调节性T细胞可在不产生及不响应转化生长因子β1的情况下介导抑制功能。
J Exp Med. 2002 Jul 15;196(2):237-46. doi: 10.1084/jem.20020590.
9
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.通过转化生长因子β诱导转录因子Foxp3,使外周CD4+CD25-初始T细胞转化为CD4+CD25+调节性T细胞。
J Exp Med. 2003 Dec 15;198(12):1875-86. doi: 10.1084/jem.20030152.
10
CD28 disruption exacerbates inflammation in Tgf-beta1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-beta1.CD28缺失加剧Tgf-beta1基因敲除小鼠的炎症反应:CD4+CD25+调节性T细胞在体内的抑制作用,且不依赖自分泌Tgf-beta1。
Blood. 2004 Jun 15;103(12):4594-601. doi: 10.1182/blood-2003-08-2897. Epub 2004 Mar 11.

引用本文的文献

1
Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub.通过下调TGFβ3/GLI2/YAP1信号枢纽靶向膀胱癌干细胞和癌症相关成纤维细胞对胡芦巴碱治疗潜力的营养保健品评估
Int J Med Sci. 2025 Feb 18;22(5):1194-1207. doi: 10.7150/ijms.107228. eCollection 2025.
2
A novel GPI-anchored dominant-negative TGF-β receptor II renders T cells unresponsive to TGF-β signaling.一种新型的糖基磷脂酰肌醇(GPI)锚定的显性负性转化生长因子-β(TGF-β)受体II使T细胞对TGF-β信号无反应。
Mol Ther Oncolytics. 2023 Sep 25;31:100730. doi: 10.1016/j.omto.2023.100730. eCollection 2023 Dec 19.
3
Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment.
耗尽衰竭细胞:在肿瘤微环境中靶向调节性 T 细胞。
Front Immunol. 2022 Sep 30;13:940052. doi: 10.3389/fimmu.2022.940052. eCollection 2022.
4
Immune Tumor Microenvironment in Ovarian Cancer Ascites.卵巢癌腹水的免疫肿瘤微环境。
Int J Mol Sci. 2022 Sep 14;23(18):10692. doi: 10.3390/ijms231810692.
5
Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics.肿瘤诱导恶病质中转化生长因子-β信号通路:从分子途径到临床。
Cells. 2022 Aug 28;11(17):2671. doi: 10.3390/cells11172671.
6
Inflammation and Gastric Cancer.炎症与胃癌
Diseases. 2022 Jun 22;10(3):35. doi: 10.3390/diseases10030035.
7
In Vivo Generation of SSA/Ro Antigen-Specific Regulatory T Cells Improves Experimental Sjögren's Syndrome in Mice.体内生成 SSA/Ro 抗原特异性调节性 T 细胞可改善小鼠实验性干燥综合征。
Arthritis Rheumatol. 2022 Oct;74(10):1699-1705. doi: 10.1002/art.42244. Epub 2022 Aug 31.
8
Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior.免疫微环境和基因组改变决定三阴性乳腺癌免疫调节亚型的肿瘤行为。
Cancers (Basel). 2021 Dec 13;13(24):6256. doi: 10.3390/cancers13246256.
9
The expression profiles of chemokines, innate immune and apoptotic genes in tumors caused by Rous Sarcoma Virus (RSV-A) in chickens.鸡劳斯肉瘤病毒(RSV-A)引起的肿瘤中趋化因子、固有免疫和凋亡基因的表达谱。
Genes Immun. 2022 Feb;23(1):12-22. doi: 10.1038/s41435-021-00158-0. Epub 2021 Dec 21.
10
BMP4 Moderates Glycolysis and Regulates Activation and Interferon-Gamma Production in CD4+ T Cells.BMP4 调节糖酵解并调控 CD4+T 细胞的激活和干扰素-γ产生。
Front Immunol. 2021 Aug 3;12:702211. doi: 10.3389/fimmu.2021.702211. eCollection 2021.